Short-Term Outcome of Patients with Cirrhosis and Concurrent Portal Cavernoma Presenting with Acute Variceal Bleeding

Table 1

Demographics and clinical characteristics at admission.

Characteristic	The cavernoma group	The control group	value
Age, years	53.1 ± 11.9	53.3 ± 11.8	0.487
Sex, male, %	19/9	38/18	1
Cause of liver disease,			0.580
Chronic HBV infection	19	31
Chronic HCV infection	0	2
Alcohol	3	9
others	6	14
Hemoglobin, g/L	79.6 ± 23.9	73.2 ± 23.5	0.242
Platelet, 1000/mm3	121.7 ± 101.9	84.7 ± 57.1	0.036
WBC	5.3 ± 3.1	9.1 ± 11.3	0.091
Creatinine, µmol/L	70.0 ± 20.4	76.4 ± 20.9	0.962
ALT, IU/L	30.3 ± 19.7	41.0 ± 56.2	0.330
AST, IU/L	48.6 ± 30.3	57.2 ± 92.9	0.633
Bilirubin, µmol/L	35.9 ± 38.3	26.1 ± 22.9	0.149
Albumin, g/L	29.7 ± 7.0	30.5 ± 5.8	0.554
INR	1.3 ± 0.4	1.4 ± 0.4	0.455
Ascites, (%)	24 (85.7%)	33 (58.9%)	0.013
Encephalopathy, (%)	1 (3.6%)	1 (1.7%)	0.613
Child-Pugh grade, (%)			0.447
A	4	14
B	18	34
C	6	8
Child score	7.36 ± 2.14	7.96 ± 1.76	0.439
MELD score	15.43 ± 5.3	16.46 ± 5.4	0.851
Heart rate, beats/min	84 ± 13	83 ± 15	0.983
Systolic blood pressure, mmHg	109 ± 20	112 ± 18	0.530
Infection, (%)	7 (25%)	12 (20.7%)	0.712
Splenectomy, (%)	10 (35.7%)	9 (15.5%)	0.043

Abbreviations. HBV, hepatitis B virus; HCV, hepatitis C virus; WBC, white blood cell; ALT, alanine aminotransferase; AST, aspartate aminotransferase.